|
Name |
paecilin K
|
Molecular Formula | C33H34O15 | |
IUPAC Name* |
methyl5-hydroxy-8-[5-hydroxy-2-(1-hydroxy-4-methoxy-2-methyl-4-oxobutyl)-2-methoxycarbonyl-4-oxo-3H-chromen-8-yl]-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3H-chromene-2-carboxylate
|
|
SMILES |
COC(=O)CC(C)C(O)C1(C(=O)OC)CC(=O)c2c(O)ccc(-c3ccc(O)c4c3OC(C(=O)OC)(C3OC(=O)CC3C)CC4=O)c2O1
|
|
InChI |
InChI=1S/C33H34O15/c1-14(10-22(38)43-3)28(40)32(30(41)44-4)12-20(36)24-18(34)8-6-16(26(24)47-32)17-7-9-19(35)25-21(37)13-33(31(42)45-5,48-27(17)25)29-15(2)11-23(39)46-29/h6-9,14-15,28-29,34-35,40H,10-13H2,1-5H3/t14-,15-,28+,29+,32-,33-/m0/s1
|
|
InChIKey |
IDMKUZRJCXHKFV-MMJMNZOWSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 670.62 | ALogp: | 2.0 |
HBD: | 3 | HBA: | 15 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 218.5 | Aromatic Rings: | 5 |
Heavy Atoms: | 48 | QED Weighted: | 0.272 |
Caco-2 Permeability: | -5.247 | MDCK Permeability: | 0.00001800 |
Pgp-inhibitor: | 0.556 | Pgp-substrate: | 0.033 |
Human Intestinal Absorption (HIA): | 0.859 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.921 |
Blood-Brain-Barrier Penetration (BBB): | 0.033 | Plasma Protein Binding (PPB): | 79.18% |
Volume Distribution (VD): | 0.389 | Fu: | 12.75% |
CYP1A2-inhibitor: | 0.025 | CYP1A2-substrate: | 0.698 |
CYP2C19-inhibitor: | 0.089 | CYP2C19-substrate: | 0.086 |
CYP2C9-inhibitor: | 0.419 | CYP2C9-substrate: | 0.521 |
CYP2D6-inhibitor: | 0.034 | CYP2D6-substrate: | 0.153 |
CYP3A4-inhibitor: | 0.91 | CYP3A4-substrate: | 0.554 |
Clearance (CL): | 12.83 | Half-life (T1/2): | 0.13 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.818 |
Drug-inuced Liver Injury (DILI): | 0.969 | AMES Toxicity: | 0.027 |
Rat Oral Acute Toxicity: | 0.923 | Maximum Recommended Daily Dose: | 0.085 |
Skin Sensitization: | 0.009 | Carcinogencity: | 0.065 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.005 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005727 | 0.884 | D0T5XN | 0.266 | ||||
ENC005729 | 0.806 | D07IPB | 0.258 | ||||
ENC005735 | 0.781 | D01UBX | 0.251 | ||||
ENC005736 | 0.719 | D01XWG | 0.246 | ||||
ENC005734 | 0.702 | D0Q0PR | 0.245 | ||||
ENC005731 | 0.684 | D0C9XJ | 0.242 | ||||
ENC002448 | 0.684 | D07VLY | 0.242 | ||||
ENC003346 | 0.650 | D01XDL | 0.239 | ||||
ENC005728 | 0.620 | D0T8EH | 0.232 | ||||
ENC005730 | 0.609 | D08FPM | 0.229 |